cefoperazone has been researched along with cephalexin in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (15.38) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (46.15) | 29.6817 |
| 2010's | 5 (38.46) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chairoungdua, A; Choi, BK; Endou, H; Jung, KY; Kim, DK; Kusuhara, H; Narikawa, S; Sekine, T; Shimoda, M; Sugiyama, Y; Takeda, M; Tojo, A | 1 |
| Inui, K; Saito, H; Uwai, Y | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Collins, B; Cotter, PD; Curtis, N; Hill, C; Ross, RP | 1 |
| de Waart, DR; Duijst, S; Kunne, C; Oude Elferink, RP; Paulusma, CC; van de Wetering, K | 1 |
| Grime, K; Paine, SW | 1 |
| Bommareddy, A; Gionfriddo, MR; Heindel, GA; Mukhija, P; Vanwert, AL; Witkowski, S; Wolman, AT | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Concia, E; Marino, P; Marone, P; Verani, D | 1 |
| Brogard, JM; Comte, F | 1 |
| Kawashima, S; Koga, K; Murakami, M | 1 |
| Andrasi, M; Buglyo, P; Gaspar, A; Zekany, L | 1 |
2 review(s) available for cefoperazone and cephalexin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Pharmacokinetics of the new cephalosporins.
Topics: Cefaclor; Cefadroxil; Cefamandole; Cefazolin; Cefmetazole; Cefonicid; Cefoperazone; Cefotaxime; Cefotiam; Cefsulodin; Ceftizoxime; Cephalexin; Cephalosporins; Cephamycins; Cephradine; Humans; Intestinal Absorption; Kinetics; Moxalactam; Tissue Distribution | 1982 |
11 other study(ies) available for cefoperazone and cephalexin
| Article | Year |
|---|---|
Involvement of rat organic anion transporter 3 (rOAT3) in cephaloridine-induced nephrotoxicity: in comparison with rOAT1.
Topics: Animals; Cephaloridine; Cephalosporins; Immunohistochemistry; Kidney; Mice; Organic Anion Transporters, Sodium-Independent; Rats | 2002 |
Rat renal organic anion transporter rOAT1 mediates transport of urinary-excreted cephalosporins, but not of biliary-excreted cefoperazone.
Topics: | 2002 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
The ABC transporter AnrAB contributes to the innate resistance of Listeria monocytogenes to nisin, bacitracin, and various beta-lactam antibiotics.
Topics: Anti-Bacterial Agents; ATP-Binding Cassette Transporters; Bacitracin; Bacterial Proteins; beta-Lactam Resistance; Listeria monocytogenes; Nisin | 2010 |
Oral availability of cefadroxil depends on ABCC3 and ABCC4.
Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Biological Availability; Biological Transport; Cefadroxil; Cell Membrane; Enterocytes; Estradiol; Intestinal Absorption; Intestinal Mucosa; Jejunum; Mice; Mice, Knockout; Multidrug Resistance-Associated Proteins | 2012 |
Species differences in biliary clearance and possible relevance of hepatic uptake and efflux transporters involvement.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Bile; Body Weight; Dogs; Drug Administration Routes; Humans; Liver; Membrane Transport Proteins; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Organic Anion Transporters; Pharmaceutical Preparations; Protein Binding; Rats; Species Specificity | 2013 |
Organic anion transporter 3 interacts selectively with lipophilic β-lactam antibiotics.
Topics: Animals; Anti-Bacterial Agents; beta-Lactams; Biological Transport; Cell Line, Transformed; Humans; Mice; Organic Anion Transport Protein 1; Organic Anion Transporters, Sodium-Independent; Solubility; Structure-Activity Relationship | 2013 |
[Microbiological evaluation of the antibacterial activity of cefotaxime in comparison with other cephalosporins].
Topics: Bacteria; Cefazolin; Cefoperazone; Cefotaxime; Cefoxitin; Cefuroxime; Cephacetrile; Cephalexin; Cephaloridine; Cephalosporins; Cephalothin; Cephradine; Enterobacter; Escherichia coli; Humans; Klebsiella pneumoniae; Salmonella; Staphylococcus aureus | 1982 |
In vitro and in situ evidence for the contribution of Labrasol and Gelucire 44/14 on transport of cephalexin and cefoperazone by rat intestine.
Topics: Animals; Biological Transport; Cefoperazone; Cephalexin; Dose-Response Relationship, Drug; Emulsions; Excipients; Glycerides; In Vitro Techniques; Jejunum; Male; Organic Chemicals; Polyethylene Glycols; Rats; Rats, Wistar | 2002 |
A comparative study of capillary zone electrophoresis and pH-potentiometry for determination of dissociation constants.
Topics: Anti-Bacterial Agents; Cefaclor; Cefadroxil; Cefoperazone; Cefotaxime; Cefoxitin; Cephalexin; Cephalosporins; Electrophoresis, Capillary; Hydrogen-Ion Concentration; Kinetics; Molecular Structure; Potentiometry | 2007 |